Antitrust regulators in Brussels are moving towards blocking CK Hutchison’s £10.5bn deal to acquire O2, Telefonica’s British mobile business, unless additional concessions are offered, reports the Financial Times.
Two people close to the discussions said a draft decision by Europe’s antitrust watchdog to stop the deal is likely, in a regulatory test case that could send shockwaves through the continent’s telecoms industry.
The news comes days after the UK’s Competition and Markets Authority urged Brussels to block the acquisition. The move followed similar protests by Ofcom, Britain’s telecoms regulator, which has come out against the merger. One person close to the deal described the CMA’s intervention as helpful and in line with thinking in Brussels.
Margrethe Vestager, EU competition commissioner, said on Wednesday that she would take account of resistance in Britain. UK regulators fear the proposed merger of O2 with Hutchison’s Three could harm consumers by reducing competition and lead to increased prices.
“They work the same way as we do, so of course I take due note of what the regulators and the competition authority has said in this case,” Ms Vestager said, although she stressed that a final decision had not been taken.
British competition officials want Hutchison to carve off part of its business to create a fourth mobile operator to replace O2, a view which has support within the commission.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas